Vanguard Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $21.9K | Sell |
|
|||||
|
2022
Q4 | $131K | Sell |
|
|||||
|
2022
Q3 | $437K | Hold |
|
|||||
|
2022
Q2 | $434K | Hold |
|
|||||
|
2022
Q1 | $788K | Sell |
|
|||||
|
2021
Q4 | $640K | Hold |
|
|||||
|
2021
Q3 | $1.26M | Buy |
|
|||||
|
2021
Q2 | $1.4M | Buy |
|
|||||
|
2021
Q1 | $755K | Buy |
|
|||||
|
2020
Q4 | $596K | Sell |
|
|||||
|
2020
Q3 | $1.14M | Sell |
|
|||||
|
2020
Q2 | $1.31M | Sell |
|
|||||
|
2020
Q1 | $887K | Buy |
|
|||||
|
2019
Q4 | $2.29M | Hold |
|
|||||
|
2019
Q3 | $1.87M | Sell |
|
|||||
|
2019
Q2 | $3.19M | Sell |
|
|||||
|
2019
Q1 | $7.52M | Buy |
|
|||||
|
2018
Q4 | $5.71M | Buy |
|
|||||
|
2018
Q3 | $12M | Buy |
|
|||||
|
2018
Q2 | $14.2M | Buy |
|
|||||
|
2018
Q1 | $8.85M | Sell |
|
|||||
|
2017
Q4 | $11.4M | Buy |
|
|||||
|
2017
Q3 | $14M | Buy |
|
|||||
|
2017
Q2 | $14.1M | Buy |
|
|||||
|
2017
Q1 | $13.1M | Buy |
|
|||||
|
2016
Q4 | $12.3M | Buy |
|
|||||
|
2016
Q3 | $17.4M | Buy |
|
|||||
|
2016
Q2 | $9.74M | Buy |
|
|||||
|
2016
Q1 | $6.42M | Buy |
|
|||||
|
2015
Q4 | $13.3M | Buy |
|
|||||
|
2015
Q3 | $8.56M | Buy |
|
|||||
|
2015
Q2 | $5.96M | Buy |
|
|||||
|
2015
Q1 | $5.08M | Buy |
|
|||||
|
2014
Q4 | $1.5M | Buy |
|